Related Experiment Video
Updated: Jun 10, 2026

A Standardized Pipeline for Examining Human Cerebellar Grey Matter Morphometry using Structural Magnetic Resonance Imaging
Published on: February 4, 2022
FRAMM: Fair ranking with missing modalities for clinical trial site selection
Brandon Theodorou1, Lucas Glass2, Cao Xiao3
1University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Clinical trial site selection is improved by FRAMM, a new deep reinforcement learning framework. FRAMM enhances participant diversity and enrollment by addressing incomplete data and optimizing for both goals simultaneously.
Area of Science:
- Biomedical Informatics
- Clinical Trial Management
- Artificial Intelligence in Healthcare
Background:
- Underrepresentation of diverse populations in clinical trials impacts treatment efficacy and subgroup analysis.
- Existing clinical trial site selection methods struggle with incomplete data and balancing enrollment with diversity.
Purpose of the Study:
- To introduce FRAMM, a deep reinforcement learning framework for fair clinical trial site selection.
- To address challenges of incomplete data modalities and simultaneous optimization of enrollment and diversity.
Main Methods:
- FRAMM utilizes a modality encoder with masked cross-attention to handle missing data.
- A deep reinforcement learning approach with a custom reward function optimizes for both enrollment and fairness.
- Evaluation performed using real-world historical clinical trial data.
Main Results:
- FRAMM outperforms leading baselines in enrollment-only scenarios.
- The framework significantly improves participant diversity in clinical trials.
- Demonstrates effective trade-offs between enrollment numbers and demographic representation.
Conclusions:
- FRAMM offers a novel solution for fair and efficient clinical trial site selection.
- The framework effectively addresses data limitations and optimizes for multiple objectives.
- FRAMM has the potential to improve the generalizability and precision of clinical trial findings across diverse populations.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence studies: Biowaivers

